Clear Eye Test Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$100K
- Investors
-
5
Clear Eye Test General Information
Description
Developer of vision technology designed to enhance the quality and speed of global eyecare by offering precise and affordable optical tests digitally. The company's digital platform assists in prescription eye care and eyewear by digitizing the test process and powering flexible omnichannel experiences through the use of algorithms and machine learning, enabling clients to simulate a patient's optical prescription and visual performance, without the need for face-to-face contact.
Contact Information
Website
www.cleareyetest.comCorporate Office
- 35 V Street NorthEast
- Washington, DC 20002
- United States
Corporate Office
- 35 V Street NorthEast
- Washington, DC 20002
- United States
Clear Eye Test Timeline
Clear Eye Test Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 17-Apr-2023 | $100K | Completed | Generating Revenue | ||
| 3. Early Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 16-Sep-2022 | $2.13M | $2.13M | Completed | Generating Revenue | |
| 1. Grant | 20-Oct-2021 | $25K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Clear Eye Test Patents
Clear Eye Test Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4680092-A2 | Virtual eye disease progression monitoring and diagnostics | Pending | 15-Mar-2023 | ||
| US-20240312610-A1 | Virtual eye disease progression monitoring and diagnostics | Pending | 15-Mar-2023 | ||
| WO-2024192387-A2 | Virtual eye disease progression monitoring and diagnostics | Inactive | 15-Mar-2023 | ||
| WO-2024192387-A3 | Virtual eye disease progression monitoring and diagnostics | Inactive | 15-Mar-2023 | ||
| EP-4057886-A1 | System and method for determining prescription of corrective lenses using predictive calculations and corrected-eyesight simulation | Pending | 14-Nov-2019 | A61B3/0025 |
Clear Eye Test Signals
Clear Eye Test Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NextCorps Luminate | Accelerator/Incubator | |||
| M1C | Venture Capital | Minority | ||
| New Majority Ventures | Accelerator/Incubator | Minority | ||
| Collab Capital | Venture Capital | Minority | ||
| HLTH | PE-Backed Company |
Clear Eye Test FAQs
-
When was Clear Eye Test founded?
Clear Eye Test was founded in 2019.
-
Where is Clear Eye Test headquartered?
Clear Eye Test is headquartered in Washington, DC.
-
What is the size of Clear Eye Test?
Clear Eye Test has 6 total employees.
-
What industry is Clear Eye Test in?
Clear Eye Test’s primary industry is Other Healthcare Technology Systems.
-
Is Clear Eye Test a private or public company?
Clear Eye Test is a Private company.
-
What is Clear Eye Test’s current revenue?
The current revenue for Clear Eye Test is .
-
How much funding has Clear Eye Test raised over time?
Clear Eye Test has raised $2.23M.
-
Who are Clear Eye Test’s investors?
NextCorps Luminate, M1C, New Majority Ventures, Collab Capital, and HLTH have invested in Clear Eye Test.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process